Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.33 |
| ▸ | FTH1 | P02794 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8776958 | 0.83 | CYP3A4 (0.33) | CYP3A4FTH1CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL14183545 | 0.83 | CYP3A4 (0.33) | CYP3A4FTH1CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL14183400 | 0.80 | CYP3A4 (0.32) | CYP3A4ALDH1A1 | |
| SCHEMBL12744539 | 0.77 | CYP3A4 (0.30) | CYP3A4 | |
| SCHEMBL14183437 | 0.76 | — | — | |
| SCHEMBL14183402 | 0.74 | CYP3A4 (0.33) | CYP3A4ALDH1A1 | |
| SCHEMBL14183547 | 0.74 | CYP3A4 (0.31) | CYP3A4 | |
| SCHEMBL14183418 | 0.74 | — | — | |
| SCHEMBL14183499 | 0.73 | CYP3A4 (0.30) | CYP3A4 | |
| SCHEMBL14183489 | 0.73 | CYP3A4 (0.30) | CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 221 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200278611-A1 | A METHOD OF PREPARING A PLANAR OPTICAL WAVEGUIDE ASSEMBLY | DOW SILICONES CORP (US) | 2020-09-03 | — | — | US | claimed |
| US-20140060324-A1 | METHOD OF PREPARING GAS SELECTIVE MEMBRANE USING EPOXY-FUNCTIONAL SILOXANES | DOW CORNING CORPORATION (US) | 2014-03-06 | — | — | US | claimed |
| EP-3194501-B1 | 3D PRINTING METHOD UTILIZING A PHOTOCURABLE SILICONE COMPOSITION | DOW SILICONES CORP (US) | 2024-07-10 | — | — | EP | disclosed |
| WO-2024145273-A2 | N-MYRISTOYLTRANSFERASE INHIBITORS AND METHODS OF USE | SEATTLE CHILDREN'S HOSPITAL (D/B/A SEATTLE CHILDREN'S RESEARCH INSTITUTE) (US) | 2024-07-04 | — | — | WO | disclosed |
| EP-4392430-A1 | MOLECULAR DEGRADERS OF EXTRACELLULAR PROTEINS | Yale University (US) | 2024-07-03 | — | — | EP | disclosed |
| EP-4392168-A1 | IONIC LIQUID-BASED COMPOSITE MEMBRANES USING FUNCTIONAL CROSS-LINKERS | The Regents of the University of Colorado, a body corporate (US) | 2024-07-03 | — | — | EP | disclosed |
| US-20240181438-A1 | UNSYMMETRICAL N-HETEROCYCLIC CARBENE CATALYSTS AND METHODS USING SAME | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2024-06-06 | — | — | US | disclosed |
| CN-118103453-A | Silicone-polyolefin hybrid elastomer | 陶氏环球技术有限责任公司 | 2024-05-28 | — | — | CN | disclosed |
| US-20240165597-A1 | STERICALLY HINDERED N-ALIPHATIC N-HETEROCYCLIC CARBENE CATALYSTS AND METHODS USING SAME | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2024-05-23 | — | — | US | disclosed |
| US-20240158580-A1 | CURABLE SILICONE COMPOSITION | DOW SILICONES CORP (US) | 2024-05-16 | — | — | US | disclosed |
| WO-2024097160-A1 | TRANSITION METAL COMPLEXES FOR MRI APPLICATIONS AND METHODS OF USE | YALE UNIVERSITY (US) | 2024-05-10 | — | — | WO | disclosed |
| EP-0571965-B1 | Curable silicone composition | DOW CORNING TORAY SILICONE (JP) | 1998-10-21 | — | — | EP | disclosed |
| EP-0567079-B1 | Curable resin composition | DOW CORNING TORAY SILICONE (JP) | 1997-03-26 | — | — | EP | disclosed |
| EP-0541988-B1 | Organopolysiloxane and method for the preparation thereof | DOW CORNING TORAY SILICONE (JP) | 1997-03-12 | — | — | EP | disclosed |
| US-5530075-A | CURABLE RESIN, ORGANOPOLYSILOXANE HAVING EPOXY GROUPS | DOW CORNING TORAY SILICONE CO., LTD. (JP) | 1996-06-25 | — | — | US | disclosed |
| US-5358983-A | Flexible, heat resistance, hardness | DOW CORNING TORAY SILICONE CO., LTD. (JP) | 1994-10-25 | — | — | US | disclosed |
| US-5310843-A | Organopolysiloxane and method for the preparation thereof | DOW CORNING TORAY SILICONE CO., LTD. (JP) | 1994-05-10 | — | — | US | disclosed |
| EP-0571965-A1 | Curable silicone composition | Dow Corning Toray Silicone Company, Limited (JP) | 1993-12-01 | — | — | EP | disclosed |
| EP-0567079-A1 | Curable resin composition | Dow Corning Toray Silicone Company, Limited (JP) | 1993-10-27 | — | — | EP | disclosed |
| EP-0541988-A1 | Organopolysiloxane and method for the preparation thereof | Dow Corning Toray Silicone Company, Limited (JP) | 1993-05-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240181438-A1 | UNSYMMETRICAL N-HETEROCYCLIC CARBENE CATALYSTS AND METHODS USING SAME | NDC1, NUDC, NSFL1C | CYP3A4 408/4885FTH1 1362/4885CYP2C9 2032/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.